Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Digoxin for the Reinduction of Radioiodine Uptake in Metastatic or Locally Advanced Non-medullary Thyroid Carcinoma

NCT05507775 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT05507775
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05507775 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Digoxin for the Reinduction of Radioiodine Uptake in Metastatic or Locally Advanced Non-medullary Thyroid Carcinoma
Lead sponsor
Radboud University Medical Center
Phase
Not applicable
Overall status
Completed
Start date
December 6, 2022
Completion date
January 1, 2024
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-medullary thyroid carcinoma